unknown
Stage
About
ViroTact develops an innovative molecular diagnostic test to detect Covid-19, enabling fast, scalable, and low-cost point-of-care testing to increase testing capacity in the Netherlands and globally.
Explore ViroTact's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.